Emily Meyer is an Endocrinologist and has embarked on a PhD in corticosteroid-binding globulin (CBG) in septic shock at the Royal Adelaide Hospital and University of Adelaide. She has published a number of reviews and research papers in the field, demonstrating an association between a reduction in high-affinity CBG and septic shock mortality. Findings which have been presented at both the ESA-SRB and USENDO annual meetings, receiving the ESA IPSEN and Endocrine Society’s Early Career Travel Awards. As part of her PhD she has developed a novel homogenous ligand binding assay using Surface Plasmon Resonance (SPR) technology. Using this technique, she has characterised the binding affinities of both high- and low-affinity CBG to a library of steroid ligands, at temperatures and at physiological and acidaemic pH to mimic the pathophysiological conditions of septic shock. These findings will be presented at this year’s ESA Bryan Hudson Awards. Research interests outside her PhD include SGLT2i associated diabetic ketoacidosis, particularly in the perioperative setting.
Abstracts this author is presenting: